From Nasdaq: 2025-04-14 02:30:00

Novartis (NVS) shares closed 4% higher at $107.52 after announcing a $23 billion investment in U.S. facilities. Expected quarterly earnings are $2.06 per share, up 14.4% year-over-year, with revenues of $12.86 billion, up 8.7%. Despite a 3% downward revision in EPS estimates, Novartis carries a Zacks Rank #3 (Hold).

Johnson & Johnson (JNJ) shares rose 2% to $151.73. Expected EPS for the upcoming report is $2.57, down -5.2% from last year, with a Zacks Rank #3 (Hold). Get insights on 5 stocks set to double in 2024, including potential home run opportunities under the radar.



Read more at Nasdaq: Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?